高级检索

    晚期乳腺癌一线内分泌治疗联合贝伐珠单抗未能获得生存获益

    Addition of Bevacizumab to Endocrine Therapy as First-Line Treatment for Advanced Breast Cancer Cannot Increase in Survival

      摘要
      • HTML全文
      • 参考文献(7)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回